Rothschild Wealth LLC
Source: SEC Form 13F · as of Mar 2026Rothschild Wealth LLC holds 9 biotech & pharma companies tracked by BioSniper, totaling $3.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$3.4M
BioSniper AIPage context preserved
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 1,161 | $897K |
| CATXPerspective Therapeutics, Inc. | 164,821 | $687K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 8,483 | $479K |
| EXELEXELIXIS, INC. | 8,297 | $356K |
| GILDGILEAD SCIENCES, INC. | 2,128 | $297K |
| INCYIncyte Corp. | 2,978 | $280K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 658 | $218K |
| INTSINTENSITY THERAPEUTICS, INC. | 23,294 | $137K |
| MEDSDataMeds AI, Inc. | 20,293 | $2K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.